Close
Patheon

News Releases

  • 22 Feb 2016
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with Grünenthal, an independent, family-owned, international research-based pharmaceutical group headquartered in Aachen, Germany, to serve as its preferred development partner for its products made using Grünenthal’s innovative abuse deterrent formulation technology INTAC®. Patheon was selected tomore...
  • 22 Feb 2016
    DURHAM, Carolina del Nord--(BUSINESS WIRE)--Patheon, fornitore di spicco di portata globale di servizi per lo sviluppo e la produzione di prodotti farmaceutici, ha annunciato quest'oggi di aver sottoscritto un accordo strategico con Grünenthal, un gruppo farmaceutico internazionale indipendente a conduzione familiare basato sulla ricerca con sede generale ad Aachen, Germania, ai sensi del quale la società fungerà da partner preferenziale per lo sviluppo dei prodotti realizzati con l'innovativamore...
  • 17 Feb 2016

    Patheon Introduces Xcelodose® Automated Encapsulator Technology at Milton Park, U.K. Facility

    Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has added a new filling technology that significantly reduces the time needed for formulation development and stability testing at its Milton Park, U.K., facility. The Xcelodose ® 600 S Automated Encapsulator, supports early phase development for oral dose products.This technology adds to the site’s breadth of services, from early development to life cyclemore...

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

 
 

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com